Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees

Globally, dengue virus (DENV) is one of the most widespread vector-borne viruses. Dengue disease affects populations in endemic areas and, increasingly, tourists who travel to these countries, but there is currently no approved vaccine for dengue. A phase 3 efficacy trial with Sanofi-Pasteur's...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Velumani, Sumathy, Toh, Ying Xiu, Balasingam, Shobana, Archuleta, Sophia, Leo, Yee Sin, Gan, Victor C., Thein, Tun Linn, Wilder-Smith, Annelies, Fink, Katja
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2016
Témata:
Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963049/
https://ncbi.nlm.nih.gov/pubmed/26889737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1126012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky